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Disability Stage is an Independent Risk Factor for Mortality in
Medicare Beneficiaries Aged 65 Years and Older
Sean Hennessy, PharmD, PhD, Jibby E. Kurichi, MPH, Qiang Pan, MA,
Joel E. Streim, MD, Hillary R. Bogner, MD, Dawei Xie, PhD, Margaret G. Stineman, MDAbstractBackground: Stages of activity limitation based on activities of daily living (ADLs) and instrumental activities of daily living (IADLs)
have been found to predict mortality in persons aged 70 years and older but have not been examined in Medicare beneficiaries
aged 65 years and older using data that are routinely collected.
Objective: To examine the association between functional stages based on items of ADLs and IADLs with 3-year mortality in
Medicare beneficiaries aged 65 years and older, accounting for baseline sociodemographics, health status, smoking, subjective
health, and psychological well-being.
Design: A cohort study using the Medicare Current Beneficiary Survey (MCBS) and associated health care utilization data.
Setting: Community administered survey.
Participants: The study included 9698 Medicare beneficiaries aged 65 years and older who participated in the MCBS in 2005-2007.
Main Outcome Measures: Death within 3 years of cohort entry.
Results: The overall mortality rate was 3.6 per 100 person years, and 3-year cumulative mortality was 10.3%. Unadjusted 3-year
mortality was monotonically associated with both ADL stage and IADL stage. Adjusted 3-year mortality was associated with ADL
and IADL stages, except that in some models the hazard ratio for stage III (which includes persons with atypical activity limitation
patterns) was numerically lower than that for stage II.
Conclusion: We found nearly monotonic relationships between ADL and IADL stage and adjusted 3-year mortality. These findings
could aid in the development of population health approaches and metrics for evaluating the success of alternative economic,
social, or health policies on the longevity of older adults with activity limitations.Introduction
More than 56 million Americans (19% of the U.S.
population) had at least one disability in 2010 according
to the Survey of Income and Program Participation [1].
This number is expected to grow substantially as the
Baby Boom generation ages. Approximately 25% of
people aged 65 years and older have difficulty with at
least one basic activity of daily living (ADL), and an
additional 14% have difficulty performing at least one
higher level instrumental activity of daily living (IADL)
[2] as defined by the International Classification of
Functioning, Disability and Health (ICF) [3]. This high
prevalence of activity limitation, along with the growing
number of elderly persons in the United States, will
present a challenge to the Medicare program. Sox [4]1934-1482 ª 2015 by the American Academy of Physical Medicine and Reh
http://dx.doi.org/10.1016/j.pmrj.2015.05.014has asserted that approaching each patient strictly as
an individual is an obsolete organizing principal for U.S.
health care today and that population health ap-
proaches are the best alternative for improving and
maintaining the health of people in the community. In
response to this assertion and to a 2007 Institute
of Medicine report calling for the creation of compre-
hensive disability monitoring systems based on ICF
terminology and concepts, Stineman et al [5] developed
ICF-based staging systems for ADLs and IADLs, which are
summarized in Table 1. Disability staging systems that
are based on regularly collected survey data and that
predict mortality can be used to advance the goal of
using population-based approaches to monitor and
improve health. The 5 ADL and 5 IADL stages represent
meaningful population-level measures of activityabilitation  Open access under CC BY-NC-ND license.
Table 1
Disability staging system based on activities of daily living and instrumental activities of daily living derived from the Medicare Current Beneficiary
Survey
Stage ADL Domain IADL Domain
Stage 0: no disability Can eat, toilet, dress, bathe/shower, get in/out of
bed or chairs, and walk without difficulty
Can use the telephone, manage money, prepare meals,
do light housework, shop for personal items, and do
heavy housework without difficulty
Stage I: mild disability Eating, toileting, dressing, and bathing/showering are
not difficult; may have difficulty getting in/out of
bed or chairs and/or walking
Using the telephone, managing money, preparing meals,
and doing light housework are not difficult; may have
difficulty shopping for personal items and/or doing
heavy housework
Stage II: moderate disability Eating and toileting are not difficult; may have
difficulty dressing, bathing/showering, getting
in/out of bed or chairs, and/or walking
Using the telephone and managing money are not
difficult; may have difficulty preparing meals, doing
light housework, shopping for personal items, and/or
doing heavy housework
Stage III: severe disability Difficulty with eating and/or toileting but not with all
ADLs
Has difficulty using the telephone and/or managing
money but not all IADLs are difficult
Stage IV: complete disability All ADLs are difficult All IADLs are difficult
ADL ¼ activity of daily living; IADL ¼ instrumental activity of daily living.
1216 Disability and Mortalitylimitation that could be used by the Centers for Medi-
care and Medicaid Services (CMS) to monitor the prev-
alence of activity limitations in the Medicare population
and assess the effects of efforts to promote the health,
function, and survival of persons with defined types and
severities of activity limitation. Such monitoring can be
performed using data already routinely collected as part
of the Medicare Current Beneficiary Survey (MCBS) [6].
The staging systems that we examined (Table 1) are
based on the ADL and IADL domains such that stage
0 represents “no” limitation; stage I, “mild” limitation;
stage II, “moderate” limitation; stage III, “severe” lim-
itation; and stage IV, “complete” limitation within those
domains. These hierarchical staging systems reflect the
most common patterns of functional loss and recovery
and specify clinically meaningful patterns of increasing
difficulty with self-care and more complex instrumental
skills. At mild stages of limitation, people are able to
perform all but the typically hardest activities without
difficulty, whereas at more advanced stages, even
the easiest activities (ie, those least frequently re-
ported as difficult) become limited. Stage III in the
ADL and IADL systems was designed as a “nonfitting”
stage to accommodate people with atypical patterns
of disability.
ADL and IADL stages have shown expected associa-
tions with age and comorbidity [7] and were found to be
associated with mortality using data from 1994 National
Health Interview Survey linked to data from the Second
Longitudinal Study of Aging [8,9]. However, to our
knowledge, the association between MCBS-derived ADL
and IADL stages and mortality is unknown, and yet this
information is important if stages are to be used to
perform risk stratification for persons on the basis of
disability in population health approaches. If these
stages are independently associated with mortality,
they might be useful for identifying Medicare benefi-
ciaries who might benefit from interventions toameliorate activity limitation or for evaluating the
success of policies to help the disabled elderly. We
therefore sought to assess whether the MCBS-derived
ADL and IADL stages predict 3-year mortality after
adjusting for medical comorbidity in a nationally
representative sample of Medicare beneficiaries aged 65
years and older. We hypothesized that increasing ADL
and IADL stages would be independently associated with
increasing 3-year mortality, with the possible exception
of the nonfitting stage III.
MethodsStudy CohortWe studied MCBS participants [6,10]. The MCBS is a
systematic sample of Medicare beneficiaries who are
interviewed (or whose proxies are interviewed) and
whose subsequent health care utilization is recorded.
Each beneficiary or proxy is interviewed for a total of
4 years: the entry year plus 3 years of follow-up. The
resulting data consist of 2 linkable data sets: (1) Access
to Care (which records baseline health status and the
results of an interview ascertaining functional ability)
and (2) Cost and Use (which includes respondents’
Medicare claims data). Each respondent is assigned a
survey weight that reflects the number of Medicare
beneficiaries for whom that individual stands for in the
survey results [10].
Our study cohort consisted of members of the 2005,
2006, and 2007 entry panels who had reached their 65th
birthday by the date of panel entry (n ¼ 9700). We
restricted our study to beneficiaries aged 65 years and
older because we anticipated that associations between
disability stages and death might differ between elderly
and nonelderly Medicare beneficiaries and because of
the small number of deaths in persons younger than
65 years. We excluded 2 beneficiaries for whom key ADL
1217S. Hennessy et al. / PM R 7 (2015) 1215-1225variables were missing and 3 beneficiaries for whom key
IADL variables were missing. Thus 9695 persons were
included in the analyses. This study was approved by the
University of Pennsylvania Institutional Review Board.Baseline ADL and IADL StagesWe characterized each respondent by baseline ADL
and IADL stage using methods described previously
[5,7]. Ability to perform each ADL and IADL without
difficulty versus with difficulty was ascertained at
baseline based on responses to questionnaire items
about 6 activities per domain [5,11]. The ADLs were
eating, toileting, dressing, bathing/showering, getting
in or out of bed/chairs, and walking. The IADLs were
using the telephone, managing money, preparing meals,
doing light housework, shopping for personal items, and
doing heavy housework.OutcomeThe outcome of interest was the occurrence and
timing of death from any cause during the 3-year follow-
up period, as recorded in the Cost and Use files.CovariatesWe ascertained baseline covariates in 4 domains:
sociodemographics, comorbidities, smoking, and psy-
chological well-being and subjective health.
Sociodemographic variables included gender, race or
ethnic group (non-Hispanic white, non-Hispanic black,
Hispanic, or other), and age (65-74, 75-84, or 85
years). Education was categorized as high school grad-
uate or higher or below high school graduate. Income
was categorized as $25,000 or >$25,000 per year.
Social living circumstance was classified as lives alone,
lives with spouse, lives with children, or other.
Baseline self-reported comorbidities were conditions
or events that a doctor ever told the beneficiary he or
she had or that occurred within the past year. With
some of the conditions noted in Table 2, we also
assessed relationships with acuity, that is, initial diag-
nosis within the past year or more than a year ago.
The medical conditions consisted of rheumatoid
arthritis, arthritis other than rheumatoid, hypertension,
myocardial infarction, angina or coronary artery dis-
eases, congestive heart failure, heart valve problems,
rhythm disturbance, stroke, cancer other than skin,
osteoporosis, broken hip, asthma or chronic obstructive
pulmonary disease, Parkinson disease, amputation,
diabetes type 1, 2, or other, mental retardation,
Alzheimer disease, mental or psychiatric conditions,
depression, hardening of the arteries, and inconti-
nence/urinary catheterization. Sensory variables were
having difficulty with vision and hearing. Smoking was
assessed at baseline and classified as never, past, orcurrent. Psychological well-being variables were ascer-
tained at baseline and consisted of difficulty concen-
trating (yes or no), feeling sad or blue (all of the time,
most of the time, some of the time, a little of the time,
or none of the time), and lost interest or pleasure in
social activities (yes or no).
Perceived overall health was recorded as excellent,
very good, good, fair, or poor. Comparative general
health status relative to a year ago was recorded as much
better, somewhat better, about the same, somewhat
worse, ormuchworse. Amount of time that health limited
contactwith friends and family during thepastmonthwas
recorded as none, some, most, or all of the time.AnalysisAll analyses incorporated the complex design of MCBS
such as stratification, clustering, and weights [12].
Baseline covariates were first examined among persons
at different baseline ADL and IADL stages. Hazard ratios
and 95% confidence intervals (CIs) for the associations
between baseline ADL and IADL stage and 3-year mor-
tality were then estimated using proportional hazard
models. A multivariable model for each domain (ADL or
IADL stages) was fit as follows: (1) unadjusted associa-
tions between 3-year mortality and each variable were
assessed; (2) an intermediate model was fit that
included prespecified variables (ie, age, gender, race,
education, social living circumstances, hypertension,
myocardial infarction, angina or coronary artery dis-
eases, congestive heart failure, heart valve problems,
rhythm disturbance, stroke, cancer other than skin,
osteoporosis, broken hip, emphysema or asthma,
Parkinson disease, obviously paralyzed, diabetes type
1, 2, or other, mental retardation, Alzheimer disease,
mental or psychiatric conditions, depression, hardening
of the arteries, smoking, psychological status and mood,
global health perceptions, comparative health to a year
ago, and social consequences of health), as well as any
variable associated with 3-year mortality using a
threshold of P < .2 in the unadjusted models; and
(3) covariates were then removed through backward
selection one by one starting from the one with the
largest P value, until all P values were <.05.
The validity of the proportional hazards assumption
was tested by examining an interaction term between
each variable in the final model and follow-up time,
classified as <1.5 years or 1.5 years after baseline (1.5
years was chosen since it is the midpoint of 3 years). We
included time interactions for each variable in any
domain-specific model that had a P value <.05 before a
final backward selection procedure was conducted to
obtain the final models with main effects and in-
teractions. Finally, to explore effects of potential
colinearity between disability stage and perceived
health status, we fit an additional Cox proportional
hazard model excluding perceived health status
Table 2
Baseline characteristics of enrollees of the 2005, 2006, and 2007 entry panels of the Medicare Current Beneficiary Survey who had reached their 65th birthday by activity of daily living and
instrumental activity of daily living stage
Variable
All
(N ¼ 9695)
ADL Stage IADL Stage
0
(N ¼ 6713)
I
(N ¼ 1609)
II
(N ¼ 758)
III
(N ¼ 512)
IV
(N ¼ 103)
P
Value
0
(N ¼ 6076)
I
(N ¼ 1676)
II
(N ¼ 713)
III
(N ¼ 1014)
IV
(N ¼ 216)
P
Value
Sociodemographic data
Gender
Female 55.8 53.7 58.8 63.2 67.0 63.6 <.001 50.3 73.7 71.7 51.3 64.3 <.001
Race
Non-Hispanic white 81.7 83.1 80.1 77.5 75.1 58.6 <.001 83.1 82.0 76.5 78.3 64.4 <.001
Non-Hispanic black 7.5 6.8 8.5 10.4 10.8 11.4 7.0 7.8 9.1 7.9 17.0
Hispanic 7.3 6.7 8.3 8.8 9.6 21.6 6.7 6.7 10.0 10.0 15.2
Other 3.4 3.4 3.1 3.3 4.5 * 3.2 3.5 4.5 3.8 *
Age, y
65-74 56.9 62.3 45.5 39.6 37.4 32.9 <.001 63.3 50.0 45.0 36.4 21.3 <.001
75-84 33.4 31.0 39.6 39.8 39.8 40.7 30.7 36.5 40.3 41.2 41.2
85 9.8 6.7 14.9 20.6 22.8 26.4 6.0 13.5 14.6 22.4 37.5
Education
Below high school
graduate
24.9 21.2 31.8 35.8 41.1 49.1 <.001 20.1 28.0 36.8 40.8 51.9 <.001
Income
$25,000 50.7 56.4 39.0 32.5 31.0 21.6 <.001 57.9 40.6 33.1 35.0 18.6 <.001
Social living circumstance
Alone 29.4 28.5 31.7 32.8 32.1 25.2 <.001 27.8 35.9 32.8 29.2 20.8 <.001
Spouse 55.9 59.6 49.3 42.8 41.0 39.6 60.9 46.6 45.0 48.1 33.7
Children 9.3 7.1 12.8 16.8 18.3 27.3 6.6 11.7 14.6 16.9 34.0
Other 5.3 4.7 6.2 7.6 8.5 * 4.7 5.8 7.7 5.8 11.4
Health status conditions
Rheumatoid arthritis 7.9 5.6 12.7 16.3 14.4 10.4 <.001 5.4 11.5 15.3 12.9 12.7 <.001
Arthritis other than rheumatoid
>1 y 12.2 12.2 13.2 9.9 11.2 10.6 <.001 11.9 13.4 11.9 12.3 9.9 <.001
1 y 34.4 28.3 50.8 49.1 53.7 43.4 27.5 51.2 55.1 39.1 39.7
Hypertension
>1 y 11.5 11.7 11.8 9.3 10.1 * <.001 11.9 10.5 10.7 10.9 8.6 <.001
1 y 49.2 44.9 60.4 60.8 60.5 66.2 43.8 60.1 62.5 58.3 58.1
Myocardial infarction
>1 y 10.5 8.6 16.1 14.2 15.4 15.3 <.001 8.6 12.7 13.9 16.9 18.4 <.001
1 y 1.9 1.3 3.4 3.3 3.9 * 1.3 2.3 6.3 2.6 *
Angina or coronary artery diseases
>1 y 5.7 5.2 7.6 7.6 6.1 * <.001 5.0 7.4 7.1 6.4 9.4 <.001
1 y 3.6 2.5 6.4 6.7 6.2 * 2.5 4.7 7.3 6.3 7.5
Congestive heart failure
>1 y 3.5 2.4 6.3 5.9 7.4 * <.001 2.2 5.9 6.1 5.8 11.4 <.001
1 y 2.5 1.2 4.8 8.3 7.1 * 1.0 4.2 8.2 5.3 7.6
Heart valve problems
>1 y 4.3 3.8 5.7 5.9 5.7 * <.001 3.7 6.0 4.9 5.6 * <.001
1 y 3.2 2.6 5.0 4.4 5.3 * 2.1 5.6 5.6 5.3 *
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Rhythm disturbance
>1 y 8.0 7.4 9.1 8.5 13.6 * <.001 7.3 8.8 11.5 9.2 10.9 <.001
1 y 8.4 6.4 12.9 14.9 14.8 12.0 5.8 13.2 15.4 12.6 13.8
Stroke
>1 y 8.0 5.2 12.7 18.6 17.9 26.2 <.001 5.0 9.8 15.7 16.7 33.2 <.001
1 y 1.8 1.1 2.8 4.5 5.3 11.2 1.0 2.4 4.4 4.0 9.6
Cancer other than skin
>1 y 12.0 11.6 12.8 12.5 15.8 * <.001 11.0 15.0 12.1 14.1 11.6 <.001
1 y 5.0 4.3 6.1 6.9 8.9 * 4.4 5.6 7.9 6.2 *
Osteoporosis 16.8 14.2 22.1 25.9 25.9 22.0 <.001 12.4 26.1 29.9 21.1 23.7 <.001
Broken hip
>1 y 2.6 1.4 4.6 6.3 8.1 * <.001 1.4 4.0 5.2 5.5 11.0 <.001
1 y 0.6 0.2 0.8 2.8 1.9 * 0.2 0.6 1.8 1.6 *
Emphysema/asthma/
chronic obstructive
pulmonary disease
13.4 10.4 21.3 21.2 23.7 16.8 <.001 9.8 19.8 26.0 19.2 16.4 <.001
Parkinson disease 1.1 0.5 1.6 3.0 4.6 * <.001 0.4 1.3 2.4 2.9 9.2 <.001
Amputation 0.6 0.3 0.9 2.2 1.9 * <.001 0.4 0.8 * 1.1 * <.001
Diabetes
Type 1 2.5 1.5 4.4 5.9 5.0 * <.001 1.5 3.3 6.5 4.4 7.6 <.001
Type 2 16.0 13.5 21.1 26.0 24.2 21.7 13.5 20.6 24.7 19.5 21.3
Other type 4.9 4.5 5.9 4.4 7.4 * 4.7 4.8 5.4 6.4 6.8
Mental retardation 0.3 0.2 * * * * <.001 * * * 1.1 * <.001
Mental or psychiatric conditions
>1 y 0.5 0.5 * * * * <.01 0.3 0.8 * * * <.001
1 y 1.0 0.7 1.4 2.0 * * 0.6 0.8 * 3.0 *
Alzheimer disease 2.4 1.3 2.3 7.1 9.3 25.2 <.001 0.7 0.8 2.2 11.1 39.9 <.001
Depression
>1 y 7.2 6.1 9.4 12.2 9.0 * <.001 5.6 9.6 11.8 10.7 11.7 <.001
1 y 8.6 5.6 13.6 17.9 22.9 24.7 4.5 13.9 20.9 17.2 25.6
Hardening of the
arteries
7.1 5.8 9.5 10.3 13.4 12.2 <.001 5.3 9.5 10.7 12.2 12.4 <.001
Incontinence
Yes 27.9 21.8 37.3 50.1 53.5 66.8 <.001 20.3 41.9 46.7 38.7 61.8 <.001
Dialysis/
catheterization
0.6 0.2 * * 4.2 10.9 * 1.3 * 1.4 6.7
Vision
Has difficulty 5.9 3.4 9.5 15.0 15.8 29.7 <.001 2.5 8.2 13.5 16.3 32.9 <.001
Hearing
Has difficulty 6.2 4.6 7.9 13.4 13.8 18.4 <.001 3.0 5.6 8.5 26.0 25.6 <.001
Paralysis
>1 y 1.3 0.8 2.2 2.9 3.3 * <.001 0.7 2.0 3.0 2.2 * <.001
1 y 1.0 0.2 1.2 3.7 5.8 19.5 0.2 0.7 3.4 3.4 10.7
Smoking status
Not a smoker 44.1 44.4 41.4 43.2 47.0 54.0 .043 43.3 46.1 46.1 43.0 53.2 .046
Ever a smoker 44.0 43.7 45.2 46.2 44.0 34.4 44.3 43.2 41.7 46.4 39.6
Current smoker 11.9 11.8 13.4 10.6 9.0 11.7 12.4 10.7 12.3 10.6 7.2
(continued on next page)
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Table 2 (continued )
Variable
All
(N ¼ 9695)
ADL Stage IADL Stage
0
(N ¼ 6713)
I
(N ¼ 1609)
II
(N ¼ 758)
III
(N ¼ 512)
IV
(N ¼ 103)
P
Value
0
(N ¼ 6076)
I
(N ¼ 1676)
II
(N ¼ 713)
III
(N ¼ 1014)
IV
(N ¼ 216)
P
Value
Subjective health and psychological well-being
Difficulty concentrating 11.0 6.4 16.6 29.2 32.1 57.5 <.001 5.1 12.6 23.1 32.5 70.5 <.001
Feeling sad or blue
All of the time 1.0 0.6 1.2 3.3 2.9 * <.001 0.6 1.2 2.9 1.8 6.2 <.001
Most of the time 3.9 2.9 4.9 7.2 9.1 21.4 2.5 4.7 6.9 8.1 17.5
Some of the time 17.0 13.4 24.3 28.8 31.6 23.4 12.3 23.3 31.0 28.5 28.7
A little of the time 35.5 34.9 38.9 36.7 33.1 29.6 34.5 41.6 35.6 33.7 24.4
None of the time 42.6 48.3 30.8 24.0 23.4 15.7 50.2 29.2 23.6 27.8 23.3
Lost interest or pleasure
in social activities
10.4 6.5 15.9 23.8 27.9 43.1 <.001 5.5 15.7 25.2 21.8 35.5 <.001
Global health perceptions
Excellent 19.3 24.3 6.1 6.0 5.4 * <.001 25.7 6.4 3.7 9.1 5.4 <.001
Very good 29.3 33.7 19.3 16.2 14.8 * 34.7 21.0 12.7 19.6 9.2
Good 31.0 29.8 37.4 31.2 30.7 18.0 29.6 38.2 27.5 31.4 25.9
Fair 15.1 10.4 26.0 31.2 27.7 34.5 8.5 26.7 34.6 26.6 29.2
Poor 5.4 1.8 11.2 15.3 21.4 39.3 1.5 7.6 21.4 13.2 30.3
Comparative general health status to a year ago
Much better 4.9 5.2 4.1 4.8 3.4 * <.001 5.1 5.1 4.6 4.0 * <.001
Somewhat better 10.4 10.0 12.0 13.0 7.8 * 9.7 12.4 12.0 10.7 8.5
About the same 66.0 72.6 52.6 44.0 44.8 34.9 74.3 54.8 38.4 51.0 37.4
Somewhat worse 16.3 11.5 27.1 30.4 33.4 36.7 10.4 24.4 35.8 27.5 34.8
Much worse 2.4 0.8 4.2 7.8 10.7 19.6 0.5 3.3 9.3 6.8 16.9
Amount of time health limits contact with friends and family during the past month
None of the time 71.6 83.1 50.0 33.7 25.4 * <.001 85.9 52.5 25.4 44.6 14.8 <.001
Some of the time 17.2 12.9 29.2 29.0 30.1 16.9 11.0 31.0 30.9 28.0 18.5
Most of the time 7.1 3.0 14.2 22.0 24.0 25.5 2.3 12.7 25.9 15.5 22.2
All of the time 4.1 1.0 6.6 15.3 20.5 51.3 0.8 3.8 17.8 11.8 44.5
Outcome
3-y mortality 10.3 6.2 14.8 26.6 29.6 48.6 <.001 5.7 12.2 23.1 23.5 51.8 <.001
ADL ¼ activity of daily living; IADL ¼ instrumental activity of daily living.
* According to the policies of the Centers for Medicare and Medicaid Services, the percentage cannot be displayed because the cell size is less than 11.
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Figure 1. (A) Survival of Medicare beneficiaries aged 65 years and older by activity of daily living (ADL) stage measured at baseline. (B) Survival of
Medicare beneficiaries aged 65 years and older by instrumental ADL (IADL) stage measured at baseline.
1221S. Hennessy et al. / PM R 7 (2015) 1215-1225variables. We used SAS version 9.4 (SAS Institute, Inc,
Cary, NC) for descriptive analyses to compare the dis-
tribution of covariates according to ADL and IADL stage.
We used the survey procedures of STATA/MP 13.1 (Stata
Corp, Inc, College Station, TX) for regressions to take
into account the complex survey design.
Results
Table 2 presents baseline characteristics of Medi-
care beneficiaries aged 65 years and older by ADL and
IADL stage. As expected, the prevalences of many
disabling conditions (ie, rheumatoid arthritis,Parkinson disease, Alzheimer disease, and depression)
were associated with ADL and IADL stage, although not
monotonically in all cases. Also as expected, the
prevalence of excellent and very good perceived
health status tended to be lower in persons with higher
disability stages, although not monotonically in all
cases.
The overall mortality rate was 3.6 per 100 person
years, and the cumulative incidence of mortality over
3 years was 10.3%. Both increasing ADL stage and
increasing IADL stage were monotonically associated
with unadjusted 3-year cumulative mortality, although
the differences between stage II and III were small in
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1222 Disability and Mortalityboth the ADL and IADL staging systems (Table 2). This
finding is also reflected in the similarity of the survival
curves (Figure 1) for stages II and III, especially in the
IADL staging system. Except for these similarities in
the curves for stages II and III, there was early and
strong separation of survival curves by ADL and IADL
stage.
The interaction between ADL stage and follow-up
time was not statistically significant in the model
including health perception (P ¼ .42) or in the model
excluding it (P ¼ .33), indicating that the assumption of
proportional hazards by ADL stage was not violated. The
same was true for IADL stage in the model, including
health perception (P ¼ .85) and excluding it (P ¼ .69).
However, hazard ratios for several covariates varied by
follow-up duration. Therefore, the results presented in
Table 3 allow hazard ratios for these covariates to vary
by follow-up duration. Table 3 presents adjusted hazard
ratios (with 95% CIs) for all-cause 3-year mortality for
each ADL and IADL stage, both adjusting for and not
adjusting for perceived health status. Consistent with
the unadjusted survival curves, higher ADL and IADL
stages were associated with higher adjusted hazard ra-
tios for death, except that in the IADL models the haz-
ard ratio for stage III was numerically lower than that
for stage II.
DiscussionSummary of Key FindingsThe goal of this study was to assess the potential
utility of ADL and IADL stages for population health
applications by testing the hypothesis that disability
stages [5] are independent predictors of 3-year mor-
tality in Medicare beneficiaries aged 65 years and older.
We observed strong and early separation of unadjusted
survival curves by disability stage, except that survival
curves for IADL stages II and III overlapped. In models
assessing the independent associations of 3-year mor-
tality with ADL disability stage, we found nearly mono-
tonic relationships. IADL stage was also independently
associated with increased 3-year mortality, with hazard
ratios that were similar in magnitude to those of the ADL
stages. Because stage III includes people whose
disability patterns are outside the typical hierarchy, the
observed nonfit of that stage was expected. Our results
are consistent with those of prior studies that also found
functional limitations to be associated with higher
mortality [8,13-21].Significance of FindingsThe findings of an association between MCBS-based
ADL and IADL stages with 3-year mortality are impor-
tant because unlike earlier work with stages [7], this
study used survey data that are collected on an
1223S. Hennessy et al. / PM R 7 (2015) 1215-1225ongoing basis, which permits the annual measurement
of disability prevalence based on routinely collected
data. Specifically, these staging systems will enable
the ongoing analyses of samples representative of all
noninstitutionalized Medicare beneficiaries aged
65 years and older, which includes about 93% of all
community-dwelling U.S. residents in this age group
[22]. Stage profiles derived from such metrics can
be used to identify groups of beneficiaries who are
similar with respect to both the severity and the
nature of the activity limitation experienced. For
example, the IADL I cohort is by definition able to
do all IADLs without difficulty except heavy house-
work, whereas the IADL IV cohort has difficulty in all
IADLs.
Our findings have a number of key clinical and
policy implications. Particularly noteworthy are the
findings that the hazard ratios for IADL limitations
were of similar magnitude to those for ADL limita-
tions. This finding implies that either ADL or IADL
stages can be used to stratify populations by risk of
mortality. Second, the relationship between disability
stage and mortality was evident even after extensive
adjustments for age, comorbidity, and perceived
health status variables. Although these associations
may be due to unmeasured or residual confounding
rather than being causal, it remains possible that at
least some of the persons experiencing activity limi-
tation may have had functional deficits that were
remediable or even reversible, or they may have
faced access barriers that could be reduced or elimi-
nated. Nevertheless, the strength of associations be-
tween disability stage and death might inform policy
makers and health plan administrators who wish to
identify subsets of the Medicare population who are at
the greatest risk of death and who might benefit the
most from interventions that ameliorate activity lim-
itation. Further, such associations could facilitate the
development of metrics for evaluating the success of
economic, social, or health policies to help disabled
elderly persons. These metrics could support popula-
tion surveillance applications such as those applied in
Chart Books published periodically by the U.S.
Department of Health and Human Services [23] or as
baseline or target measures for Healthy People ob-
jectives. Third, because self-reported ADL and IADL
questions are easily collected from patients or family
members, stage assessment might prove valuable as a
clinical tool. Fourth, our findings of strong associa-
tions with mortality support the establishment of
multivariable risk indices for mortality drawing on
information from thousands of Medicare beneficiaries.
Finally, early pilot work supports development of
clinical tools for falls risk assessment, as well as for
establishing the likelihood of nursing home placement
and functional deterioration [24-27].Strengths and LimitationsA major strength of this study is its use of a repre-
sentative sample of noninstitutionalized Medicare ben-
eficiaries, which makes its results broadly generalizable
to the community-dwelling U.S. population aged 65
years and older. Other strengths of the study include
the large size and breadth of the data, the routine
collection of MCBS data, and the richness of the data
available for adjustment. A potential limitation is that
despite our best efforts to identify independent effects
of disability itself, we cannot be certain that the
observed associations with disability stage are due
wholly to persons’ activity limitations rather than to
unmeasured medical conditions and other factors that
contribute to those limitations. It may be that disability
acts as a proxy for poor health. Further, our results are
not generalizable to persons residing in long-term care
facilities or to those younger than 65 years. The
potential also exists for response bias and imperfect
recall by participants. Although inclusion of proxies
reduced selection bias, it may also have increased
measurement error [28].Conclusion
We found that ADL and IADL stages are highly asso-
ciated with 3-year mortality. As health care organiza-
tions move increasingly toward seeking population
health rather than focusing solely on the health of the
individual, these stages could prove valuable to reha-
bilitation and other health professionals. Future
research should examine associations between MCBS-
derived ADL and IADL stages and other adverse out-
comes. The utility of adding disability stages to pre-
dictive indices to identify high-risk patients in clinical
settings also deserves evaluation. Finally, it will be
important to develop and evaluate disability prevention
and management strategies to reduce the burden of
activity limitation. Stage-specific strategies might
include patient-, family-, and community-level pro-
grams implemented in medical homes, accountable care
organizations, and programs of all-inclusive care for
elders targeted to increase ADL and IADL functioning
and reduce mortality.References
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